Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | GFER | P55789 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | CFTR | P13569 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | CFD | P00746 | 1/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31720563 | 0.98 | ALDH1A1 (0.47) | ALDH1A1GAAGFERHSD17B10CFTR | |
| Hydrochloric Acid SCHEMBL1772178 | 0.98 | ALDH1A1 (0.47) | ALDH1A1GAAGFERHSD17B10CFTR | |
| Hydrochloric Acid SCHEMBL29061400 | 0.96 | ALDH1A1 (0.46) | ALDH1A1GAAGFERHSD17B10CFTR | |
| SCHEMBL27871547 | 0.86 | ALDH1A1 (0.43) | ALDH1A1GAAGFERHSD17B10CFTR | |
| SCHEMBL1554320 | 0.86 | KDM4E (0.53) | ALDH1A1HSD17B10KDM4EHPGDTSHR | |
| SCHEMBL28842276 | 0.85 | ALDH1A1 (0.46) | ALDH1A1GAAGFERHSD17B10CFTR | |
| SCHEMBL8524830 | 0.84 | ESR1 (0.47) | ALDH1A1GAAGFERHSD17B10CFTR | |
| SCHEMBL12883622 | 0.84 | ALDH1A1 (0.45) | ALDH1A1GAAGFERHSD17B10CFTR | |
| SCHEMBL10268521 | 0.84 | ALDH1A1 (0.49) | ALDH1A1GAAGFERHSD17B10CFTR | |
| SCHEMBL29749375 | 0.84 | ALDH1A1 (0.49) | ALDH1A1GAAGFERHSD17B10CFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101698647-B | Synthesis method of 2,5-diamino benzene ethanol | YIXING XINYU CHEMICAL CO LTD | 2012-10-03 | — | — | CN | claimed |
| CN-101698647-A | Synthesis method of 2,5-diamino benzene ethanol | YIXING XINYU CHEMICAL CO LTD | 2010-04-28 | — | — | CN | claimed |
| CN-122036615-A | Indazole hydrazide compound and preparation method and application thereof | 南京农业大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20260092045-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2026-04-02 | — | — | US | disclosed |
| WO-2025137307-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| US-12286435-B2 | Compound having benzo seven-membered ring structure, preparation method therefor, and use thereof | BIONNA (BEIJING) MEDICAL TECHNOLOGY CO., LTD. (CN) | 2025-04-29 | — | — | US | disclosed |
| US-20250092014-A1 | COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE | METREA BIOSCIENCES INC (US) | 2025-03-20 | — | — | US | disclosed |
| EP-4524133-A2 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | Biocryst Pharmaceuticals, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| EP-3939658-B1 | SUBSTITUTED BENZOPYRROLE AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | BIOCRYST PHARM INC (US) | 2024-10-02 | — | — | EP | disclosed |
| US-20240294494-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2024-09-05 | — | — | US | disclosed |
| US-12043610-B2 | Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| EP-0642508-A1 | TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1995-03-15 | — | — | EP | disclosed |
| EP-0638075-A1 | THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-02-15 | — | — | EP | disclosed |
| WO-1994019335-A1 | THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-09-01 | — | — | WO | disclosed |
| WO-1993008188-A1 | TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1993-04-29 | — | — | WO | disclosed |
| EP-0313740-B1 | N-PHENYL-2,2,6,6-TETRAHALOCYCLOHEXANEIMINE AND PROCESSES FOR PREPARING 2,2,6,6-TETRAHALOCYCLOHEXANEIMINE DERIVATIVE AND 2,6-DIHALOANILINE DERIVATIVE | OSAKA YUKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1993-04-07 | — | — | EP | disclosed |
| US-5001264-A | N-phenyl-2,2,6,6-tetrahalocyclohexaneimine and processes for preparing 2,2,6,6-tetrahalocyclohexaneimine derivative and 2,6-dihaloaniline derivative | OSAKA YUKI KAGUKU KOGYO KABUSHIKI KAISHA (JP) | 1991-03-19 | — | — | US | disclosed |
| US-4908479-A | N-phenyl-2,2,6,6-tetrahalocyclohexaneimine | OSAKA YUKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1990-03-13 | — | — | US | disclosed |
| EP-0313740-A2 | N-phenyl-2,2,6,6-tetrahalocyclohexaneimine and processes for preparing 2,2,6,6-tetrahalocyclohexaneimine derivative and 2,6-dihaloaniline derivative | OSAKA YUKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-05-03 | — | — | EP | disclosed |
| US-4803197-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1989-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240294494-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | C9, C5, C1QBP | ALDH1A1 1047/4885GAA 2145/4885GFER 766/4885 |
| US-12043610-B2 | Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors | C9, C5, C1QBP | ALDH1A1 1047/4885GAA 2145/4885GFER 766/4885 |
| US-20260092045-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | TFPI, F3, BTK | ALDH1A1 3179/4885GAA 4457/4885GFER 2822/4885 |
| US-12286435-B2 | Compound having benzo seven-membered ring structure, preparation method therefor, and use thereof | BRD4, BRD7, BICRA | ALDH1A1 2921/4885GAA 3511/4885GFER 3445/4885 |
| US-20250092014-A1 | COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE | LPL, LIPA, PNLIP | ALDH1A1 1201/4885GAA 19/4885GFER 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.